RocketTickers

FibroGen Announces Positive Topline Results from Three Global Ph

Long
NASDAQ:FGEN   FibroGen, Inc
FGEN: FibroGen, Inc
2018-12-20 07:00:00
FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.